CRAD-BC-Rad AB (publ)
34.90SEK-0.29%Mkt Cap: 110.10M $P/E: 23.58

C-Rad AB (publ) develops, manufactures, and sells products and systems with applications in radiotherapy for the treatment of cancer in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company off…

Key Statistics

Company
Market Cap110.10M $
Enterprise Value-9.46M $
Revenue (TTM)42.51M $
Gross Profit30.23M $
Net Income (TTM)1.00M $
Revenue/Share1.269 USD
Last Price34.90 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees98
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN
Valuation
P/E (Trailing)23.58
P/E (Forward)15.62
PEG
EV/EBITDA-1.17
EV/Revenue-0.22
P/S2.62
P/B0.08
EPS (TTM)1.48
EPS (Forward)2.26
52W Range
24.6070% of range39.40
52W High39.40 SEK
52W Low24.60 SEK
Profitability
Gross Margin71.52%
Oper. Margin18.49%
EBITDA Margin19.09%
Profit Margin2.37%
ROE3.01%
ROA2.09%
Growth
Revenue Growth15.70%
Earnings Growth505.00%
Cash Flow & Leverage
Operating CF6.80M $
CapEx (TTM)1.99M $
FCF Margin2.11%
FCF Yield0.81%
Net Debt-12.35M $
Net Debt/EBITDA-1.52
Balance Sheet
Debt/Equity0.03
Current Ratio3.34
Quick Ratio2.63
Book Value/Sh424.62 SEK
Cash/Share160.16 SEK
Dividends
Fwd Div Rate0.1000 SEK
Trail. Div Rate0.1000 SEK
Div. Yield0.29%
5Y Avg Yield
Payout Ratio6.76%
Ex-Div DateMay 8, 2026
Pay Date
Analyst Consensus
Rating
Target (Mean)45.00 SEK
Upside (mean)+28.9%
Target Range45.00 SEK45.00 SEK
# Analysts1
Ownership
Shares Out.32.12M
Float560.87K
Insiders46.49%
Institutions30.68%
Technical
SMA 5036.54 (-4.5%)
SMA 20031.89 (+9.4%)
Beta0.75
S&P 52W Chg18.16%
Avg Vol (30d)12.78K
Avg Vol (10d)5.38K
Technical Indicators
RSI (14)40.6
MACD-0.2373
MACD Signal-0.1051
MACD Hist.-0.1322
BB Upper37.75 SEK
BB Middle36.25 SEK
BB Lower34.75 SEK
BB Width8.26%
ATR (14)0.9183 SEK
Vol Ratio (20d)0.69x